Reckitt Benckiser — Mead Johnson
Tracked across 2 events · 26 articles · First seen Apr 09, 2026 · Last active Aug 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Abbott Laboratories agreed to pay $670 million to settle a portion of the litigation alleging that its preterm infant formulas cause necrotizing enterocolitis (NEC), a deadly bowel disease. The settlement, announced on August 21, 2026,…
Impact: Mead Johnson is a co-defendant in many of the NEC lawsuits. A bellwether trial against the company is underway, and the outcome could influence the resolution of other cases.
Aug 20, 2026 · 20 articles
Business
Impact: Reckitt Benckiser — Mead Johnson, a unit of Reckitt, is also facing hundreds of lawsuits regarding its Enfamil formula causing NEC. While not directly involved in this specific verdict, the ongoing litigation poses a similar risk to the company.
Apr 10, 2026 · 6 articles
70
Reckitt Benckiser — Mead Johnson faced lawsuits Abbott LaboratoriesAbbott settles preterm...
70
Abbott Laboratories faced lawsuits Reckitt Benckiser — Mead JohnsonAbbott settles preterm...
ERGEN INTELLIGENCE
Track Reckitt Benckiser — Mead Johnson live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard